366 related articles for article (PubMed ID: 29166749)
1. [New progress in clinical significance of ADAMTS13].
Shi HP; Wang ZY
Zhonghua Xue Ye Xue Za Zhi; 2017 Oct; 38(10):903-906. PubMed ID: 29166749
[No Abstract] [Full Text] [Related]
2. [Changes of ADAMTS13 Activity and TSP1 Level in Patients with Hematologic Malignancies].
Sun CF; Zhao X; Han F; Jia Q; Wang L; Lu G; Ding HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1294-1298. PubMed ID: 27784345
[TBL] [Abstract][Full Text] [Related]
3. ADAMTS-13 activity reduction in plasma of acute myeloid leukemia predicts poor prognosis after bone marrow transplantation.
Liu C; Han M; Zhao L; Zhu M; Xu Q; Song Y; Wang H
Hematology; 2019 Dec; 24(1):129-133. PubMed ID: 30322352
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of dynamic changes in hs-CRP and ADAMTS13 levels in the blood serum of patients with no-reflow after PCI operation.
Liu WB; Zou ZP; Jiang HP; Li Q; Guo FM; Wang Z; Bi ZS
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):4148-4155. PubMed ID: 27775781
[TBL] [Abstract][Full Text] [Related]
5. ADAMTS13: more than a regulator of thrombosis.
Feng Y; Li X; Xiao J; Li W; Liu J; Zeng X; Chen X; Chen S
Int J Hematol; 2016 Nov; 104(5):534-539. PubMed ID: 27696191
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of vWF, GMP-140 and ADAMTS13 in patients with aneurysmal subarachnoid hemorrhage.
Li WH; Hui CJ; Ju H
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4350-4356. PubMed ID: 29077161
[TBL] [Abstract][Full Text] [Related]
8. [Changes of ADAMTS13 activity and vWF antigen level in patients with acute myelogenous leukemia and their significance].
Zhang WJ; Han Y; Ma ZN; Wang Q; Tang YQ; Wang J; Su J; Sun AN; Wang ZY; Ruan CG; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1503-7. PubMed ID: 25543464
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional correlation of ADAMTS13.
Dong JF
Curr Opin Hematol; 2007 May; 14(3):270-6. PubMed ID: 17414218
[TBL] [Abstract][Full Text] [Related]
10. [Determination of ADAMTS13 antigen and activity levels in patients with acute myocardial infarction and acute ischemic stroke].
Dong NZ; Liu F; Ji SD; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):161-3. PubMed ID: 18788613
[TBL] [Abstract][Full Text] [Related]
11. Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.
Béranger N; Benghezal S; Savigny S; Capdenat S; Joly BS; Coppo P; Stepanian A; Veyradier A
Thromb Res; 2019 Sep; 181():29-35. PubMed ID: 31330376
[TBL] [Abstract][Full Text] [Related]
12. [A study on the significance of plasma thrombospondin1 in thrombotic thrombocytopenic purpura and the relationship between thrombospondin1 and von Willebrand factor cleaving protease (ADAMTS13)].
Liu F; Lu GY; Dong NZ; Bai X; Su J; Ruan CG
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3190-3. PubMed ID: 16405838
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic relevance of ADAMTS13 activity: evaluation of 28 patients with thrombotic thrombocytopenic purpura - hemolytic uremic syndrome clinical diagnosis.
Vucelić D; Miković D; Rajić Z; Savić N; Budisin Z; Antonijević NM; Obradović S; Jevtić D; Palla R; Valsecchio C; Peyvandi F
Srp Arh Celok Lek; 2013; 141(7-8):466-74. PubMed ID: 24073552
[TBL] [Abstract][Full Text] [Related]
14. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.
Rutten B; Maseri A; Cianflone D; Laricchia A; Cristell NA; Durante A; Spartera M; Ancona F; Limite L; Hu D; Li H; Uren NG; de Groot PG; Mannucci PM; Roest M
Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):64-74. PubMed ID: 24833640
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.
Li A; Bendapudi PK; Uhl L; Hamdan A; Kaufman RM; Makar RS
Transfusion; 2017 Sep; 57(9):2151-2158. PubMed ID: 28635017
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
18. ADAMTS13 activity is decreased in a septic porcine model. Significance for glomerular thrombus deposition.
Bockmeyer CL; Reuken PA; Simon TP; Budde U; Lösche W; Bauer M; Birschmann I; Becker JU; Marx G; Claus RA
Thromb Haemost; 2011 Jan; 105(1):145-53. PubMed ID: 21057705
[TBL] [Abstract][Full Text] [Related]
19. The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction.
Austin SK; Starke RD; Lawrie AS; Cohen H; Machin SJ; Mackie IJ
Br J Haematol; 2008 May; 141(4):536-44. PubMed ID: 18341632
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan.
Matsumoto M; Fujimura Y; Wada H; Kokame K; Miyakawa Y; Ueda Y; Higasa S; Moriki T; Yagi H; Miyata T; Murata M;
Int J Hematol; 2017 Jul; 106(1):3-15. PubMed ID: 28550351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
